Politics, like nature, abhors a vacuum. Witness how the pharmaceutical industry has succeeded in taking advantage of President Donald Trump's failure to do something—anything—about high drug prices.
After a frenzied week of revamping their Affordable Care Act replacement bill, House Republicans once again stalled a planned vote on the healthcare reform measure.
California lawmakers pushed forward Wednesday with a proposal that would substantially remake the healthcare system of the nation's most populous state by replacing insurance companies with government-funded healthcare for everyone.
While efforts to repeal and replace Obamacare faltered during the early days of the Trump administration, policies to reduce regulatory burden are moving forward.
As President Donald Trump tweets that Democrats want a bailout for insurers, AHIP and its allies say Congress needs to fund cost-sharing subsidies that are part of the Affordable Care Act.
A report by researchers at the Health Care Cost Institute found costs of services vary dramatically depending on a patient's ZIP code.
Despite a year of uncertainty and tumult, most of the CEOs at eight of the largest publicly traded insurance companies got a pay raise in 2016 for ensuring their companies weathered the storm.
A Senate committee voted 14-9 to send Dr. Scott Gottlieb's nomination as head of the U.S. Food and Drug Administration to the full Senate.
The prestigious teaching hospital is using the voluntary buyouts to rein in costs as it copes with uncertainty in the healthcare industry
The company's sales grew year over year despite the February recall of its Lotus heart valve devices.